New HIV Drug from GM tobacco Plants Under Clinical Trial
August 26, 2011| |
An antiviral preventative P2G21 antibody drug synthesized by GM tobacco is being tested in the United Kingdom to establish its safety for humans. The first phase of the trial is being carried out by the EU-funded PHARMA-PLANTA (Recombinant Pharmaceuticals from Plants for Human Health') consortium which started in June and involves 11 healthy women. Results of the trials will be released in October which could open possibilities for affordable HIV treatments especially in the world's poorest countries.
Plants have been used to produce recombinant pharmaceutical protein, such as human insulin and hepatitis B vaccine. In this study, the developed antibody recognizes proteins on the surface of the HIV that block the infection. The manufactured drug used was processed from genetically modified tobacco at a ratio of 250 kg tobacco to 5 grams of purified antibody.
Details of the news can be seen at http://cordis.europa.eu/fetch?CALLER=EN_NEWS&ACTION=D&SESSION=&RCN=33735
| |
Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
-
See more articles:
-
News from Around the World
- Measures Identified for Immediate Reprieve of Hunger in the Horn of Africa
- Call for Free Access to Information on Crop Biotech
- Namibia to Implement Biosafety Regulations
- Variants of Wheat Stem Rust Race Detected in Mozambique and Zimbabwe
- The Open Forum on Agricultural Biotechnology Launched in Ghana
- Ghanaian Minister Sounds Off Biotech to Address Environmental Challenges
- Diagnostic Kit for Potato Cyst Nematode Detection
- Breeding Ozone Tolerant Plants
- Multiple Strategies to Control Resistant Western Corn Rootworm
- 3-gene Herbicide Tolerant Soybean
- GM Crop Planting in Vietnam Set for 2012
- Genetically Modified Maize Successfully Completed in Dak Lak Province
- China's Key Scientist Promotes 3-line Hybrid Bt Cotton
- Soybean Planting in Vietnam to be Given a Boost
- Solomon Islanders Plant Vitamin A-Rich Potatoes
- OGTR Invites Comments on Commercial Release Application of GM Canola
- Prime Minister Supports Biotechnology for Agriculture Development in Bangladesh
- New Molecular Biology and Biotech Studies, Biotech Communication Efforts Shared in Symposium
- Experts Investigate the Status of Food Supply and Demand in China
- Heat Stress on Wheat in Europe - More of a Problem than Drought
- On Mosses and Biotechnology in Germany from a German Professor's Interview
- New HIV Drug from GM tobacco Plants Under Clinical Trial
-
Research Highlights
- Scientists Discover Key Mechanism that Regulates Shape and Growth of Plants
- Pyramiding of Modified Bt genes in Chickpea for Better Resistance to Pod Borer
- Inheritance and Mapping of Gene Controlling Beta-carotene in Cucumber
-
Beyond Crop Biotech
- Scientists Explain How Chronic Stress Causes DNA Damage
- New genetically-engineered vaccines target Rift Valley Fever
- Geneticists Discover New Toadlet in Pilbara, Australia
-
Announcements
- 5th Annual Global Biogas Congress in Brussels
- 9th ICRISAT-CEG Training Course on Molecular Plant Breeding
-
Resources
- Consumer Information and Agro-biotechnology: The Experience of Malaysia
-
Read the latest: - Biotech Updates (April 17, 2024)
- Gene Editing Supplement (April 10, 2024)
- Gene Drive Supplement (February 22, 2023)
-
Subscribe to BU: - Share
- Tweet